Dorzagliatin is a first-in-class oral glucokinase activator (GKA) indicated for the management of Type 2 diabetes mellitus. By functioning as a glucose sensor in the pancreas and liver, this medication… Read more
Dorzagliatin is a first-in-class oral glucokinase activator (GKA) indicated for the management of Type 2 diabetes mellitus. By functioning as a glucose sensor in the pancreas and liver, this medication regulates blood sugar levels by enhancing insulin secretion and promoting glucose utilization. Pharmaceutical and analytical laboratories require reliable research materials to support the development and rigorous quality control of this therapy. The category includes high-quality Dorzagliatin reference standards, which are essential for quantitative analysis, method validation, and precise impurity profiling. Additionally, the collection offers relevant pharmaceutical impurities, metabolites, and stable isotope-labelled compounds. These tools are critical for scientists conducting stability studies, routine batch release testing, and pharmacokinetic investigations. By providing consistent and accurate materials, this selection enables the necessary identification and quantification of compounds required for regulatory compliance and safety in ongoing diabetes research.